MET gene fusions have been primarily identified in lung cancer such as the HLA-DRB1-MET (Davies et al., 2017; Blanc-Durand et al., 2020), KIF5B-MET (Gow et al., 2018), MET-UBE2H (Zhu et al., 2018a), and MET-ATXN7L1 (Zhu et al., 2018b). This evidence concerns the gene MET and lung carcinoma.